TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (TCRX)

CUSIP: 89854M101

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 6 signals
Share change
+2,378,550
SEC-reported price per share
$7.94
Number of holders
65
Value change
+$19,079,789
Number of buys
38
Number of sells
14
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
63,951,630

Security key

89854M101

Report period

Q1 2024

Institutions

65

Top holders

10

Ownership snapshot

Top reported holders of TCRX - TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
EcoR1 Capital, LLC
Disclosed value leader
Lynx1 Capital Management LP
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F 3/4/5 Highest disclosed value: $30,459,418 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Lynx1 Capital Management LP has the largest disclosed position value at $30.46M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Lynx1 Capital Management LP's linked filing trail.
Disclosed position value Top 5
EcoR1 Capital, LLC $29.15M
Christoph H. Westphal $10.9M
Lynx1 Capital Management LP $30.46M
ADAGE CAPITAL PARTNERS GP, L.L.C. $22.74M
BVF INC/IL $17.43M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
EcoR1 Capital, LLC
13F 3/4/5
Company · 10%+ Owner
—
denominator unverified
$29,150,000
5,000,000 shares
— 31 Dec 2023
Christoph H. Westphal
3/4/5
10%+ Owner
—
denominator unverified
$10,898,266
2,193,472 shares
— 20 Jul 2021
Lynx1 Capital Management LP
13F
Company
13F
—
denominator unverified
$30,459,418
5,224,600 shares
— 31 Dec 2023
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
—
denominator unverified
$22,737,000
3,900,000 shares
— 31 Dec 2023
BVF INC/IL
13F
Company
13F
—
denominator unverified
$17,428,633
2,989,474 shares
— 31 Dec 2023
BAKER BROS. ADVISORS LP
13F
Company
13F
—
denominator unverified
$16,235,337
2,784,792 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
65
Shares
34,291,369
Rows available
65
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q2 2026 Across Filers

Q2 2026 holders
59
Q1 2024 holders
65
Holder diff
6
Investor Q2 2026 Shares Q1 2024 Shares Share Diff Share Chg % Q2 2026 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .